TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

HEALTHA2Z

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

HEALTHA2Z

ST13

US500000078104331

Classe

5

Pedido

78104331

Registro

2805770

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

33

Atualização mais recente

20/03/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5

Data de depósito

23/01/2002

Data de registro

13/01/2004

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

20/03/2024

Última transação

20/03/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

13/02/2001

Primeiro uso no comércio

13/02/2001

Código do desenho

1

Tipo de titular

03

Localização do titular

DEER PARK, NY, US

Examinador

PERRY, KIMBERLY B

Unidade examinadora

M30

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

BLI INTERNATIONAL INC.
A&Z Pharmaceutical Inc.
A&Z Pharmaceutical Inc.

Representantes

Stephen R. Barrese Dilworth & Barrese, LLP

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF ACNE, ANEMIA, ARTHRITIS, ASTHMA, BACTERIAL INFECTIONS, COLD and COUGH, CONSTIPATION, DANDRUFF, DIARRHEA, DISEASES OF THE CENTRAL NERVOUS SYSTEM, FEVER, FUNGAL INFECTIONS, HEMORRHOIDS, HERPES, HEARTBURN, INFLAMMATION, INTESTINAL GAS, MIGRAINES, NASAL AND SINUS CONGESTION, NAUSEA, POOR RESPIRATION, RESPIRATORY INFECTIONS, SORE THROAT, STOMACH ACHE, MOUTH PAIN CAUSED BY TEETHING; AND MUSCLE PAIN PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION OF ACNE, ANEMIA, ARTHRITIS, ASTHMA, BACTERIAL INFECTIONS, COLD and COUGH, CONSTIPATION, DANDRUFF, DIARRHEA, DISEASES OF THE CENTRAL NERVOUS SYSTEM, FEVER, FUNGAL INFECTIONS, HEMORRHOIDS, HERPES, HEARTBURN, INFLAMMATION, INTESTINAL GAS, MIGRAINES, NASAL AND SINUS CONGESTION, NAUSEA, POOR RESPIRATION, RESPIRATORY INFECTIONS, SORE THROAT, STOMACH ACHE, MOUTH PAIN CAUSED BY TEETHING, AND MUSCLE PAIN; AMINO ACIDS FOR USE AS NUTRITIONAL SUPPLEMENTS; ANESTHETIC FOR SURGICAL PURPOSES; TOPICAL ANESTHETICS; ANESTHETICS FOR NON- SURGICAL USE; ANTIBIOTICS; ANTIBIOTICS; ANTIBIOTIC CREAMS; ANTIBIOTIC OINTMENTS; ANTIBIOTIC TABLETS; ANTIHISTAMINES AND ANTIHISTAMINE COMBINATIONS IN THE NATURE OF COLD AND ALLERGY REMEDIES; CALCIUM SUPPLEMENTS FOR THE TREATMENT OF OSTEOPOROSIS; CALCIUM SUPPLEMENTS FOR THE PREVENTION OF OSTEOPOROSIS; CARDIOVASCULAR PHARMACEUTICALS; CONTRACEPTIVE FOAMS; CONTRACEPTIVE SPONGES; ORAL CONTRACEPTIVES; DENTAL NEEDS, NAMELY MEDICATED MOUTHWASH; DENTAL NEEDS, NAMELY DENTAL ABRASIVES; DENTAL NEEDS, NAMELY DENTAL AMALGAMS; DENTAL NEEDS, NAMELY DENTAL BLEACHING GELS; DENTAL NEEDS, NAMELY DENTAL IMPRESSION MATERIALS; DENTAL NEEDS, NAMELY MEDICATED TOOTH PASTE; ROOM DEODORANTS; DIAGNOSTIC PREPARATIONS FOR CLINICAL OR MEDICAL LABORATORY USE; DIAPER RASH OINTMENT; DIET AIDS, NAMELY DIET CAPSULES AND DIET PILLS; ELECTROLYTE REPLACEMENT SOLUTIONS; ELECTROLYTE REPLACEMENT TABLETS; ENZYMES FOR USE AS A DIETARY SUPPLEMENT; EYE DROPS; EYE OINTMENTS; MEDICATED FOOT POWDER; MEDICATED HAIR GROWTH STIMULANTS; NON-MEDICATED HAIR GROWTH STIMULANTS; GEL FOR USE AS PERSONAL LUBRICANT; PREGNANCY TEST KITS FOR HOME USE; MEDICATED HAIR SHAMPOO; MEDICATED SKINCARE PREPARATIONS; SLEEP AIDS, NAMELY SLEEPING PILLS AND TABLETS; VAGINAL PREPARATIONS, NAMELY ANTI-FUNGALS; MEDICATED NAILCARE AND NOSECARE PREPARATIONS; AND NUTRACEUTICALS FOR USE AS DIETARY SUPPLEMENTS; AND HERBAL SUPPLEMENTS

Publicações

Histórico de despachos e eventos da marca no USPTO.

33 publicações encontradas

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

20/03/2024

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

20/03/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

20/03/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

20/03/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

17/10/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

24/09/2014

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - MAILED

26/09/2013

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

26/09/2013

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

26/09/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

26/09/2013

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

24/09/2013

E89R

TEAS SECTION 8 & 9 RECEIVED

24/09/2013

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

24/09/2013

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

30/04/2009

PLGL

ASSIGNED TO PARALEGAL

30/01/2009

E815

TEAS SECTION 8 & 15 RECEIVED

27/01/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

13/01/2004

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/11/2003

DOCK

ASSIGNED TO EXAMINER

06/11/2003

CFIT

CASE FILE IN TICRS

05/11/2003

SUPC

STATEMENT OF USE PROCESSING COMPLETE

28/10/2003

IUAF

USE AMENDMENT FILED

26/09/2003

MAIL

PAPER RECEIVED

26/09/2003

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

12/08/2003

PUBO

PUBLISHED FOR OPPOSITION

20/05/2003

NPUB

NOTICE OF PUBLICATION

30/04/2003

MAIL

PAPER RECEIVED

26/03/2003

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

13/01/2003

GNFR

FINAL REFUSAL E-MAILED

16/10/2002

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/07/2002

MAIL

PAPER RECEIVED

25/07/2002

GNRT

NON-FINAL ACTION E-MAILED

06/05/2002

DOCK

ASSIGNED TO EXAMINER

01/05/2002

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace HEALTHA2Z ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.